Home Search

chemotherapy - search results

If you're not happy with the results, please do another search
Calm patient and infusion

Scientists create a test to predict chemotherapy resistance in patients

Scientists have developed a test which successfully predicts whether cancer will resist common forms of chemotherapy treatment.
Cancer in the blood outbreak and treatment for malignant cells in a human body caused by carcinogens and genetics with a cancerous cell as an immunotherapy and leukemia or lymphoma symbol and medical therapy as a 3D render.

A novel approach to cancer chemotherapy

Richard F. Ludueña, Professor Emeritus at the University of Texas Health San Antonio, discusses his innovative approach to cancer chemotherapy, which could significantly enhance its effectiveness.
Brain Tumor

New target to combat chemotherapy resistance in deadly brain cancer

For patients battling glioblastoma, a highly aggressive and deadly form of brain cancer, resistance to chemotherapy remains a significant obstacle.
Delivery drones outside a hospital building

Drone chemotherapy becomes an NHS net zero cancer strategy

NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.
breast cancer chemotherapy, cholesterol

Ordinary drug could prevent heart damage from breast cancer chemotherapy

Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.
lung cancer chemotherapy, US healthcare

US healthcare: Black people less likely to receive lung cancer chemotherapy

Boston Medical Center researchers found that Black individuals, above all other racial groups, are less likely to receive lung cancer chemotherapy.
protect hair from chemotherapy, cancer medicine

Scientists discover way to protect hair from chemotherapy

Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
chemotherapy data

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.
Interactions between Microbiomes, Viruses, and Cancer

Interactions between Microbiomes, Viruses, and Cancer

The University of South Florida and Tampa General Hospital Cancer Institute launches the “Microbial Oncogenesis and Cancer Therapy” consortium.
Calm patient and infusion

Breakthrough in treating aggressive breast cancer improves patient survival

A new treatment approach for aggressive breast cancers significantly improves survival rates for patients.

New grant targets hidden heart damage in cancer patients

A team of researchers from King's College London has been awarded £850k to develop imaging tests that detect heart damage caused by cancer.
Smiling Doctor Comforting Patient in Clinic

Faster cancer diagnoses reduce wait times for 80,000 patients

The UK government’s £26 billion NHS investment has enabled 80,000 more people to receive cancer diagnoses or all-clear results within 28 days.
Open air vaccination session in an african village during corona virus pandemic

WHO issues first-ever report on invasive fungal diseases

The World Health Organization (WHO) has published its first-ever report addressing the lack of medicines and diagnostic tools for invasive fungal diseases.

£5.5 million pledged to transform bowel cancer care

Research institutes have committed £5.5 million in funding for a world-leading research team tasked with making personalised medicines for bowel cancer patients.
Calm patient and infusion

First-ever NHS treatment approved for advanced Hodgkin lymphoma

New combination therapy will be available on the NHS, offering new hope to people with advanced Hodgkin lymphoma.
Figure 1. Proposed method for creating a holobiont from engineered minimal genome endosymbionts (derived from JCVI-Syn3B) that regenerate progenitor cells in liver tissue. Fluorescently labeled endosymbiont chassis bacteria with a cationic lipid coating (1) pick up protein coronas comprised of blood peptides as they traffic to the liver (2). The labeled bacteria can be visualized in the tissue (3). Once inside the host cells, the engineered endosymbionts secrete transcription factors that affect the genetic circuits of the cell (4), with limited replication with the host cytoplasm (5). After sustained reprogramming by the secreted transcription factors, the function of the holobiont is redirected (6) toward progenitor cells that can regenerate damaged liver tissue (7). Figure created using Biorender.

Tracing evolution’s blueprint: Minimal genome life and the engineering of synthetic endosymbiosis

Roksana Riddle and Christopher H. Contag from Michigan State University discuss the concept of endosymbiosis, how it has evolved, and present strategies to engineering endosymbionts and their applications in developing innovative therapies.
Unrecognizable pharma research scientist selecting the only set of drugs personalized by genome sequencing in a lineup of pills and tablets. Healthcare concept for pharmacogenomics, pharmacogenetics.

CYP genes and haplotypes in personalised medicine

Brian Tait, Chief Scientific Officer at Haplomic Technologies Pty Ltd, focuses here on CYP genes, haplotypes, and their applications in personalised medicine.
Selection of healthy rich fiber sources vegan food for cooking

Reducing oxidative stress: Antioxidants key in the fight against non-communicable diseases

Non-communicable diseases (NCDs) thrive on oxidative stress, an imbalance of reactive oxygen species. This review delves into the crucial interplay between antioxidant enzymes and dietary antioxidants.
Hand scientists study health care and researchers doing some research with dropper chemical testing and working in life science laboratory.

Could medical imaging innovation be the catalyst for precision medicine?

We all have a unique face, fingerprint, voice, and signature, so why wouldn’t we have a unique response to the medicine and treatments we receive? Mark Hitchman, Managing Director at Canon Medical Systems UK, explores this question.

Follow Us

Advertisements